• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ATRICURE, INC. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ATRICURE, INC. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX Back to Search Results
Model Number CDK-1413
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Cardiac Tamponade (2226); Pericardial Effusion (3271)
Event Date 07/11/2019
Event Type  Death  
Manufacturer Narrative
Case-(b)(4).The device was not returned for evaluation and the device history review was unable to be completed as the relevant device lot/serial number was not reported or able to be ascertained.
 
Event Description
It was reported on (b)(6) 2019 that on (b)(6) 2019 a male patient underwent the epicardial portion of a convergent procedure.On (b)(6) 2019, the patient presented to the er and was diagnosed with pericardial effusion.The patient was admitted, 500 cc of serous-sanguineous fluid was tapped, was started on medications and a pleural drain was put in place.On (b)(6) 2019 output was down to 225 cc per day.The drain was removed on (b)(6) 2019.An echocardiogram on (b)(6) 2019 showed only a trace of fluid, the patient was discharged home on (b)(6) 2019.On (b)(6) 2019 the patient presented to the er with tamponade symptoms, was admitted, and taken to operating room.The pericardium was opened, clear fluid was drained, and pleural drain was placed.The patient was placed on iv steroids, colchicine, toradol.The patient is in recovery.This was a procedural complication.There was no reported device malfunction.
 
Manufacturer Narrative
(b)(4) follow up report: it was reported on (b)(6) 2019, patient health continued to decline until patient expired on (b)(6) 2019.It was also reported that the patient had hepatitis c and had just finished a round of experimental medication.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX
Type of Device
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX
Manufacturer (Section D)
ATRICURE, INC.
7555 innovation way
mason OH 45040
MDR Report Key8878563
MDR Text Key153813233
Report Number3011706110-2019-00037
Device Sequence Number1
Product Code OCL
Combination Product (y/n)N
PMA/PMN Number
K142084
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 09/09/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/09/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberCDK-1413
Device Catalogue NumberCDK-1413
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Date Manufacturer Received07/12/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
-
-